Gilead Sciences: Annual Report
Gilead Sciences
Annual Report (print + interactive)
Gilead is a Fortune 500 biopharma developing therapies for life-threatening diseases. This AR highlights Gilead's strategy of working on illnesses affecting huge populations such as HIV, and on much smaller scale diseases. With this approach, Gilead has gained a broader perspective that allows them to succeed and still always see the big picture. Click here to view the website.

Recognized in Graphis & Black Book AR 100.
Gilead Sciences: Annual Report
8
435
0
Published:

Gilead Sciences: Annual Report

Gilead Sciences: Annual Report
8
435
0
Published: